Add BrightSurf on Google Email

Can patient groups remain independent with drug company funding?

A new study highlights the risk of patient organizations losing independence due to funding from pharmaceutical companies. Researchers propose establishing a single database to track payments made to patient groups, doctors, and hospitals to improve transparency.

SourceUniversity of Bath·JournalInternational Journal of Social Determinants of Health and Health Services·TypeData/statistical analysis·DateJan 2, 2025

New study highlights ethical challenges in conducting cannabis research in Canada

A recent study published in Social Science & Medicine reveals the complexities of conducting cannabis research in Canada, where researchers face structural barriers and concerns about scientific integrity. The study suggests key solutions to increase public funding, enhance transparency, and promote independence in research.

SourceCentre for Addiction and Mental Health·JournalSocial Science & Medicine·TypeSurvey·DateDec 19, 2024

UTA study suggests simple steps may improve team ethics

A UT Arlington study suggests that speaking up is key to ethical decision-making in research groups. The researchers found that fostering an environment where everyone feels empowered to voice concerns can help prevent unethical behavior. An 'ethical champion' who steps up to speak out against potential issues was a common finding.

SourceUniversity of Texas at Arlington·JournalScience and Engineering Ethics·TypeObservational study·DateSep 30, 2024

New call for joint effort to bolster research integrity

A new article by leading researchers emphasizes the need for a coordinated approach among all stakeholders to improve trust in research. The authors outline roles for each group, from funders to media outlets, to work together to fortify science integrity.

SourceDigital Science·JournalFrontiers in Research Metrics and Analytics·TypeCommentary/editorial·DateAug 17, 2023

New research in JNCCN raises concerns about clinical trial bias from undisclosed censoring

A recent study published in JNCCN found that 33 out of 81 studies lacked transparency on censoring, which can introduce bias and affect trial results. The researchers emphasize the need for improved transparency and reporting in clinical trials to ensure patients and clinicians make informed decisions.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateDec 15, 2021

World-leading pharma collaborates call for plain language summaries of peer-reviewed medical journal articles

Pharmaceutical companies in the Open Pharma collaboration recommend developing plain language summaries of peer-reviewed medical research articles. The summaries should be understandable, unbiased, non-promotional, and easily accessible. This move aims to make medical publishing more open and inclusive for all audiences.

SourceTaylor & Francis Group·JournalCurrent Medical Research and Opinion·TypeCommentary/editorial·DateSep 12, 2021